Source: Biomedicine & Pharmacotherapy. Unidades: FMVZ, FM
Subjects: NEOPLASIAS RENAIS, WESTERN BLOTTING, METÁSTASE NEOPLÁSICA, FIBRONECTINAS, FIBROBLASTOS, GLICOPROTEÍNAS, EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE
ABNT
CHAVES, Karen Cristina Barbosa et al. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy. Biomedicine & Pharmacotherapy, v. 66, n. 6, p. 464-468, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2012.04.003. Acesso em: 24 ago. 2024.APA
Chaves, K. C. B., Turaça, L. T., Pesquero, J. B., Mennecier, G., Dagli, M. L. Z., Chammas, R., et al. (2012). Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy. Biomedicine & Pharmacotherapy, 66( 6), 464-468. doi:10.1016/j.biopha.2012.04.003NLM
Chaves KCB, Turaça LT, Pesquero JB, Mennecier G, Dagli MLZ, Chammas R, Schor N, Bellini MH. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy [Internet]. Biomedicine & Pharmacotherapy. 2012 ; 66( 6): 464-468.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.biopha.2012.04.003Vancouver
Chaves KCB, Turaça LT, Pesquero JB, Mennecier G, Dagli MLZ, Chammas R, Schor N, Bellini MH. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy [Internet]. Biomedicine & Pharmacotherapy. 2012 ; 66( 6): 464-468.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1016/j.biopha.2012.04.003